Recent Advances in Liposomal-Based Anti-Inflammatory Therapy

Liposomes can be seen as ideal carriers for anti-inflammatory drugs as their ability to (passively) target sites of inflammation and release their content to inflammatory target cells enables them to increase local efficacy with only limited systemic exposure and adverse effects. Nonetheless, few li...

Descripción completa

Detalles Bibliográficos
Autores principales: van Alem, Carla M. A., Metselaar, Josbert M., van Kooten, Cees, Rotmans, Joris I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309101/
https://www.ncbi.nlm.nih.gov/pubmed/34371695
http://dx.doi.org/10.3390/pharmaceutics13071004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309101/
https://www.ncbi.nlm.nih.gov/pubmed/34371695
http://dx.doi.org/10.3390/pharmaceutics13071004

Ejemplares similares